SARAH POLANTZ: Open Payments
NPI 1760926927 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 133 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $59 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $498 |
| Neurocrine BioSciences, Inc. | 26 | $294 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $274 |
| Alkermes, Inc. | 11 | $203 |
| Vanda Pharmaceuticals Inc. | 11 | $190 |
| Otsuka America Pharmaceutical, Inc. | 9 | $150 |
| Lundbeck LLC | 11 | $141 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Almatica Pharma LLC | 3 | $62 |
| Bausch Health US, LLC | 3 | $62 |
Products named: VRAYLAR, INGREZZA, REXULTI, CAPLYTA, LYBALVI, HETLIOZ, Auvelity, FANAPT.
Industry payments across PA — which companies pay providers there.
